alpha-Conotoxin VC 1.1

Star0

DB05724ExperimentalSmall molecule

Investigated for use/treatment in pain (acute or chronic).

Mechanism: ACV1 specifically blocks a subtype of a class of receptors in the peripheral nervous system called neuronal nicotinic acetylcholine receptors (nAChR).
Curator reviewed
Primary indication: Investigated for use/treatment in pain (acute or chronic).Curator reviewed
Formula / weight: C₇₁H₁₀₃N₂₃O₂₅S₄ · 1806.98 g/mol (avg)
Also known as: alpha-Conotoxin VC1.1
Code names: ACV-1

Resolves to

Compound

UNII5U5J1KR8NUCAS467428-30-4ChEMBLCHEMBL3104237

Structure

InChIKeyKJQOYUHYAZGPIZ-PIJHVLQJSA-NSMILES

CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@H](NC1=O)C(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N2

Targets

Q9GZZ6CHRNA10

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with alpha-Conotoxin VC 1.1, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account